Indian state drug regulator orders sample checks on all oral liquid solutions: Report
The drug regulator of India’s Maharashtra state has ordered sample checks on all oral liquid solutions in the state, asking for reports on the levels of diethylene glycol and ethylene glycol, CNBC TV18 reported on Thursday.
The regulator’s direction comes a day after Indian health authorities said they had halted all production of New Delhi-based Maiden Pharmaceuticals following a WHO report that its cough and cold syrups exported to Gambia may be linked to the deaths of dozens of children there.
For the latest headlines, follow our Google News channel online or via the app.
The WHO said last week that laboratory analysis of four Maiden products - Promethazine Oral Solution, Kofexmalin Baby Cough Syrup, Makoff Baby Cough Syrup and Magrip N Cold Syrup - had “unacceptable” amounts of diethylene glycol and ethylene glycol, which can be toxic and lead to acute kidney injury.
Gambian police, in a preliminary investigation report on Tuesday, said that the deaths of 69 children from acute kidney injury was linked to the cough syrups made in India and imported via a US-based company.
Read more: UAE doctors warn of health risks linked to sugar-free soda, sweeten
Also Read
-
WHO issues warning on Indian cough syrup linked to 66 Gambian child deaths
The World Health Organization has warned that a deadly batch of cough mixture connected to the deaths of dozens of children in Gambia may have been ... World News -
India finds violations in factory making cough syrup linked to Gambia deaths
Indian authorities have halted production of cough syrup at a factory of Maiden Pharmaceuticals, a state minister said on Wednesday, after a WHO ... World News -
UAE doctors warn of health risks linked to sugar-free soda, sweeteners
Doctors in the UAE are warning people to reduce their intake of sugar-free drinks, after a recent study revealed they could lead to increased risk of ... Gulf
